Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / BML Capital Management, LLC
Form 13F · Q2 2026

BML Capital Management, LLC

CIK 1616824Filed 2026-08-0713F-HR View the filing on EDGAR ↗
$176M
Reported book value
18
Positions
12
Quarters on record
Top 50
Positions

BML Capital Management, LLC — holdings

Top 15 positions of 18, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ACRS Aclaris Therapeutics Inc12.0M−16.0%$63M36.0%
2AVIR Atea Pharmaceuticals Inc7.0M−1.5%$32M18.4%
3ENGN Engene Therapeutics Inc6.7M—$12M6.6%
4KHC Kraft Heinz Co465,000+272.0%$11M6.2%
5OM Outset Med Inc2.5M+32.5%$11M6.2%
6KMX Carmax Inc172,500+11.3%$9M5.2%
7TILLYS INC Tillys Inc2.1M+0.0%$9M5.1%
8PMVP Pmv Pharmaceuticals Inc5.3M+0.2%$7M4.1%
9TIL Instil Bio Inc645,600+0.0%$5M2.8%
10TARGET CORP Target Corp37,500+0.0%$5M2.8%
11ORMP Oramed Pharmaceuticals Inc866,269−72.6%$4M2.4%
12JANX Janux Therapeutics Inc154,961+0.0%$2M1.4%
13PLRX Pliant Therapeutics Inc1.5M+0.0%$2M1.0%
14CNTB Connect Biopharma Hldgs Ltd573,287+40.2%$1M0.8%
15IMA Imagenebio Inc200,730+0.0%$1M0.7%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.